<?xml version="1.0" encoding="UTF-8"?>
<p>PWID remain, globally and overall more so in MENA, one of the hardest‐to‐reach and most stigmatized KPs, which impedes the collection of epidemiological data (both risk group size estimates and biological measures) to track PWID through the HIV cascade and inform policy 
 <xref rid="jia225102-bib-0002" ref-type="ref">2</xref>, 
 <xref rid="jia225102-bib-0006" ref-type="ref">6</xref>, 
 <xref rid="jia225102-bib-0007" ref-type="ref">7</xref>, 
 <xref rid="jia225102-bib-0008" ref-type="ref">8</xref>. Despite noticeable progress in the collection of HIV prevalence data in MENA, HIV incidence data remain scarce among all populations groups 
 <xref rid="jia225102-bib-0004" ref-type="ref">4</xref>. Among PWID, only three cohort‐type HIV incidence studies have been conducted; in Afghanistan 
 <xref rid="jia225102-bib-0009" ref-type="ref">9</xref>, Pakistan 
 <xref rid="jia225102-bib-0010" ref-type="ref">10</xref> and Iran 
 <xref rid="jia225102-bib-0011" ref-type="ref">11</xref>, and all indicated substantial incidence 
 <xref rid="jia225102-bib-0004" ref-type="ref">4</xref>. Quantifying HIV incidence among PWID in MENA is urgently needed to provide baseline data to track progress towards UNAIDS target of reducing the number of new HIV infections among young people and adults by 75% by 2020 
 <xref rid="jia225102-bib-0002" ref-type="ref">2</xref>.
</p>
